Yes. Chronic low-grade inflammation is one of the most consistent drivers of skin aging in the peer-reviewed literature. It doesn't produce pain or fever. It runs quietly in the background and progressively degrades skin structure.
The framing that has become dominant is inflammaging — chronic, sub-clinical inflammation that accompanies biological aging and accelerates it (Franceschi, 2000). In skin, inflammaging drives an enzyme family called matrix metalloproteinases (MMPs), which cleave the collagen and elastin fibers that give skin its structure (Fisher, 2002).
The downstream visible pattern: reduced elasticity, thinner dermis, slower wound healing, more visible fine lines, and increased reactivity. In women approaching perimenopause and beyond, inflammaging compounds the collagen loss driven by estradiol decline — the two processes reinforce each other.
The clinically-available measurement is high-sensitivity C-reactive protein (hs-CRP), a blood marker of chronic inflammation that's calibrated to detect the small elevations that matter for aging biology (not the large elevations that come from acute infection).
Interventions with evidence for lowering hs-CRP: omega-3 supplementation, consistent sleep, resistance training, whole-food anti-inflammatory eating patterns (Mediterranean-style), stress reduction, and treating oral health issues.
hs-CRP is one of the nine biomarkers on the JenSkin panel — because it's one of the few numbers that lets you actually see whether your interventions are working.